These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 11136282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.
    Hirschowitz BI, Simmons J, Mohnen J.
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1795-806. PubMed ID: 11683694
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Zollinger-Ellison syndrome. Relation to Helicobacter pylori-associated chronic gastritis and gastric acid secretion.
    Fich A, Talley NJ, Shorter RG, Phillips SF.
    Dig Dis Sci; 1991 Jan; 36(1):10-4. PubMed ID: 1984995
    [Abstract] [Full Text] [Related]

  • 10. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
    Eissele R, Brunner G, Simon B, Solcia E, Arnold R.
    Gastroenterology; 1997 Mar; 112(3):707-17. PubMed ID: 9041231
    [Abstract] [Full Text] [Related]

  • 11. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M, Pospai D, Forestier S, Vatier J, Vallot T.
    Clin Ther; 1993 Mar; 15 Suppl B():22-31. PubMed ID: 8205592
    [Abstract] [Full Text] [Related]

  • 12. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E, Hendel L, Gustafsen J, Hendel J.
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.
    Stolte M, Meining A, Schmitz JM, Alexandridis T, Seifert E.
    Aliment Pharmacol Ther; 1998 Mar; 12(3):247-53. PubMed ID: 9570259
    [Abstract] [Full Text] [Related]

  • 18. Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease.
    Blonski WC, Katzka DA, Lichtenstein GR, Metz DC.
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):441-4. PubMed ID: 15756097
    [Abstract] [Full Text] [Related]

  • 19. Prospective study of the long-term efficacy and safety of lansoprazole in patients with the Zollinger-Ellison syndrome.
    Jensen RT, Metz DC, Koviack PD, Feigenbaum KM.
    Aliment Pharmacol Ther; 1993 Apr; 7 Suppl 1():41-50, discussion 61-6. PubMed ID: 8490079
    [Abstract] [Full Text] [Related]

  • 20. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
    Fiocca R, Mastracci L, Attwood SE, Ell C, Galmiche JP, Hatlebakk J, Bärthel A, Långström G, Lind T, Lundell L, LOTUS trial collaborators.
    Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.